GlassScriptPhysician profile
Eric M Schallock
NPI 1477874600
$1,652.32
in general payments reported to CMS, 2019-2025
26 companies · $403 in 2025
The $403 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $264 · 2022: $336 · 2023: $332 · 2024: $317 · 2025: $403.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,053.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,052.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $284.75 | 2021-2025 | Verquvo, Januvia, Steglujan |
| Astrazeneca Pharmaceuticals LP | $182.71 | 2021-2025 | Airsupra, Breztri, Farxiga |
| Teva Pharmaceuticals USA, INC. | $130.71 | 2021-2025 | Austedo, Austedo Xr |
| Amgen INC. | $126.60 | 2024-2025 | Otezla, Repatha, Repatha |
| Lilly USA, LLC | $121.59 | 2021-2025 | Mounjaro |
| Sanofi Pasteur INC. | $112.70 | 2022-2024 | |
| Glaxosmithkline, LLC. | $79.00 | 2021-2024 | Trelegy Ellipta, Arexvy, Shingrix |
| Abbvie INC. | $78.63 | 2024-2025 | |
| Vanda Pharmaceuticals INC. | $71.23 | 2025 | Fanapt |
| Astellas Pharma US INC | $43.66 | 2023-2024 | Veozah |
| Sanofi-Aventis U.S. LLC | $42.57 | 2021-2022 | |
| Lundbeck LLC | $38.35 | 2024 | Rexulti |
| Pfizer INC. | $38.21 | 2023-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $38.19 | 2021-2022 | |
| Novo Nordisk INC | $35.93 | 2025 | Wegovy |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corcept Therapeutics | $32.38 | 2025 | Korlym |
| Biohaven Pharmaceutical Holding Company LTD. | $30.10 | 2022 | |
| Genentech USA, INC. | $26.24 | 2021 | |
| Sage Therapeutics, LLC | $24.28 | 2024 | |
| Exact Sciences Corporation | $20.59 | 2024 | Cologuard Collection Kit |
| Bayer Healthcare Pharmaceuticals INC. | $19.49 | 2023 | |
| Inspire Medical Systems, INC. | $17.44 | 2025 | Inspire |
| Novartis Pharmaceuticals Corporation | $16.97 | 2024 | |
| Roche Diagnostics Corporation | $14.55 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $13.07 | 2021 | |
| Ultragenyx Pharmaceutical INC. | $12.38 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Schallock listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.